Pancreatic cancer is one of the most frequently fatal gastrointestinal malignancies, but postoperative adjuvant therapy has gradually improved prognosis of patients with pancreatic cancer. Further unresectable locally advanced pancreatic cancer has become resectable following adjuvant therapy, and in some cases even during adjuvant surgery. As a result of the increase in long-term survival due to multidisciplinary treatment, there has also been an increase in the resection of recurrent pancreatic cancer. Ef fective multidisciplinary therapy is essential to improving prognosis of patients with pancreatic cancer. For that reason, it is also important that a treatment policy be established through detailed communication between the surgeons who decide on operability, the radiologists responsible for the radiation therapy, and the medical oncologists responsible for the chemotherapy. We will explain the current status and prospects of surgical treatment for invasive pancreatic ductal cancer through an presentation of the outcomes of the patients with pancreatic cancer at this institution.